2020

New York Times Calls for End to All-Male, All- White Cockpit

The Times article asserts that there is not enough gender and racial diversity in the airline pilot industry.

1.2 Million Injuries Reported After Receiving COVID Vax: CDC Data

VAERS data show total of 1,247,131 reports of adverse events from all age groups following COVID-19 vaccination.

Musk’s Ties to the Chinese Communist Party

Elon Musk is heavily invested in China.

Pfizer Tests Lyme Disease Vaccine on Kids, but Experts Question Need

Pfizer on Tuesday said results of Phase 2 clinical trials of its experimental Lyme disease vaccine delivered “positive” results, including among pediatric trial participants.

Democrats Face Worsening Legal Environment on Redistricting

After New York state’s top court this week crushed Democratic hopes of coming out ahead in this decade’s redistricting cycle, the party faces an increasingly precarious legal environment in the hyper-partisan battle over drawing legislative lines.

Ending Border Wall Construction Cost DHS $72 Million: Mayorkas

Department of Homeland Security (DHS) Secretary Alejandro Mayorkas told House members Wednesday that it has cost taxpayers roughly $72 million to halt construction on the wall along the U.S. southern border.

U.S. Economy Shrinks by 1.4%: Recession Fears

Inflation at 40-year high.

DHS Sets Up ‘Disinformation Governance Board’ to Fight ‘Misinformation’

Nina Jankowicz, a fellow for the Wilson Center, confirmed reports that she would direct the board, sharing her official government portrait on her social media profile.

‘Soul-Sustaining Operations’: South Carolina Gov Makes Sure Churches Can’t Be Labeled ‘Non-essential’

South Carolina Gov. Henry McMaster (R) is protecting churches after houses of worship across the country were shuttered as a result of government restrictions amid the COVID-19 pandemic.

FDA Rubber-Stamps Remdesivir for Infants Without Evidence of Safety, Efficacy

The U.S. Food and Drug Administration (FDA) on Monday approved the use of the antiviral therapy, remdesivir, to treat COVID-19 in infants four weeks and older.

Latest news

- Advertisement -spot_img